These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20022040)

  • 21. Editorial: Urinary retention in women.
    Br Med J; 1976 Jun; 1(6025):1554. PubMed ID: 1276768
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
    Takita T; Kondo A; Mitsuya H; Otani T
    Hinyokika Kiyo; 1987 Sep; 33(9):1375-84. PubMed ID: 2449057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with alpha-adrenoceptor antagonists.
    Andersson KE
    World J Urol; 2002 Apr; 19(6):390-6. PubMed ID: 12022707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do alpha1-adrenoceptor antagonists improve lower urinary tract symptoms by reducing bladder outlet resistance?
    Barendrecht MM; Abrams P; Schumacher H; de la Rosette JJ; Michel MC
    Neurourol Urodyn; 2008; 27(3):226-30. PubMed ID: 17638312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. I've been diagnosed with chronic prostatitis. What can I do for my frequent nighttime urination?
    Johns Hopkins Med Lett Health After 50; 2011 Oct; 23(8):7. PubMed ID: 22059259
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical characteristics of prostatic diseases and nursing assistance. Urination dysfunctions caused by neurogenic bladder and bladder neck fibrosis].
    Yasuda K; Shimazaki J
    Kango Gijutsu; 1982 Nov; 28(15):1971-7. PubMed ID: 6926031
    [No Abstract]   [Full Text] [Related]  

  • 27. Do alpha-blockers have a role in lower urinary tract dysfunction in multiple sclerosis?
    O'Riordan JI; Doherty C; Javed M; Brophy D; Hutchinson M; Quinlan D
    J Urol; 1995 Apr; 153(4):1114-6. PubMed ID: 7869476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Urinary retentions].
    Picotto G
    Minerva Med; 1968 Mar; 59(19):1075-9. PubMed ID: 5646220
    [No Abstract]   [Full Text] [Related]  

  • 29. Prostatic and extraprostatic alpha-adrenoceptors--contributions to the lower urinary tract symptoms in benign prostatic hyperplasia.
    Andersson KE
    Scand J Urol Nephrol Suppl; 1996; 179():105-11. PubMed ID: 8908675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Benign prostatic syndrome. Urinary urgency and micturition frequency reduced with plant preparation].
    MMW Fortschr Med; 2005 Oct; 147(40):52-3. PubMed ID: 16255520
    [No Abstract]   [Full Text] [Related]  

  • 31. The impact of alpha1-adrenoceptors on prostate cancer growth.
    Stamatiou K; Skolarikos A; Sofras F
    Urology; 2008 Apr; 71(4):756-7. PubMed ID: 18291511
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
    Colombeau P; Ballanger P
    J Urol (Paris); 1987; 93(9-10):533-5. PubMed ID: 3327892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the central role of the patient risk profile.
    Crawford ED
    BJU Int; 2005 Jun; 95 Suppl 4():1-5. PubMed ID: 15871729
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of alpha1-adrenergic blockaders in treating voiding disorders after transurethral resection of the prostate].
    Martov AG; Gushchin BL; Oshchepkov VN; Ergakov DV
    Urologiia; 2002; (5 Suppl):23-37. PubMed ID: 12518670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological treatment of urinary incontinence and difficulty in emptying the bladder in women].
    Thind P; Lose G
    Ugeskr Laeger; 1985 Dec; 147(49):3989-92. PubMed ID: 2868553
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment on: Intraprostatic and bladder-neck botulinum A toxin in treatment of males with bladder-neck dyssynergia: a pilot study.
    Michel M
    Eur Urol; 2008 Mar; 53(3):626-7. PubMed ID: 17950523
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dalphaz-retard treatment of urination disorders in men and women].
    Loran OB; Pushkar' DIu; Rasner PI
    Urologiia; 2001; (4):47-8. PubMed ID: 11569237
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
    Kessler TM; Studer UE; Burkhard FC
    J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.